Ad is loading...
DESCX
Price
$23.63
Change
-$0.30 (-1.25%)
Updated
Nov 15 closing price
RWMEX
Price
$63.76
Change
-$0.73 (-1.13%)
Updated
Nov 15 closing price
Ad is loading...

DESCX vs RWMEX

Header iconDESCX vs RWMEX Comparison
Open Charts DESCX vs RWMEXBanner chart's image
DWS ESG Core Equity C
Price$23.63
Change-$0.30 (-1.25%)
VolumeN/A
CapitalizationN/A
American Funds Washington Mutual R4
Price$63.76
Change-$0.73 (-1.13%)
VolumeN/A
CapitalizationN/A
DESCX vs RWMEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DESCX vs. RWMEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DESCX is a Buy and RWMEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWMEX has more cash in the bank: 191B vs. DESCX (240M). RWMEX pays higher dividends than DESCX: RWMEX (1.45) vs DESCX (0.00). DESCX was incepted earlier than RWMEX: DESCX (19 years) vs RWMEX (23 years). RWMEX is a more actively managed with annual turnover of: 30.00 vs. DESCX (11.00). RWMEX has a lower initial minimum investment than DESCX: RWMEX (250) vs DESCX (1000). DESCX annual gain was more profitable for investors over the last year : 28.84 vs. RWMEX (18.03). DESCX return over 5 years is better than : 54.51 vs. RWMEX (37.76).
DESCXRWMEXDESCX / RWMEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years23 years-
Gain YTD23.39413.377175%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets240M191B0%
Annual Yield % from dividends0.001.45-
Returns for 1 year28.8418.03160%
Returns for 3 years9.3410.1192%
Returns for 5 years54.5137.76144%
Returns for 10 years34.4956.3961%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LWAY23.561.17
+5.23%
Lifeway Foods
NOAH11.720.31
+2.72%
Noah Holdings Limited
PEG88.991.99
+2.29%
Public Service Enterprise Group
ANTX1.00N/A
N/A
AN2 Therapeutics
DNB12.12-0.18
-1.46%
Dun & Bradstreet Holdings